Dongnam Chemical Co., Ltd. (KRX:023450)
South Korea · Delayed Price · Currency is KRW 28,300
-50 (-0.18%)
Jun 9, 2026, 3:30 PM KST
Dongnam Chemical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Revenue | -0 | - | -0 | -0 | - | - |
| 197,836 | 194,265 | 186,399 | 166,722 | 193,401 | 160,296 | |
Revenue Growth (YoY) | 2.63% | 4.22% | 11.80% | -13.79% | 20.65% | 28.31% |
Cost of Revenue | 178,076 | 175,575 | 168,024 | 149,511 | 171,104 | 137,427 |
Gross Profit | 19,761 | 18,689 | 18,375 | 17,211 | 22,297 | 22,869 |
Selling, General & Admin | 8,277 | 8,025 | 8,250 | 8,145 | 7,936 | 6,910 |
Research & Development | 938.36 | 912.23 | 858.74 | 714.94 | 644.9 | 702.16 |
Amortization of Goodwill & Intangibles | - | - | 0.46 | 0.56 | 21.47 | 41.38 |
Other Operating Expenses | 222.59 | 224.84 | 243.5 | 215.09 | 203.87 | 178.96 |
Operating Expenses | 9,575 | 9,324 | 9,440 | 9,148 | 8,836 | 7,962 |
Operating Income | 10,186 | 9,365 | 8,935 | 8,063 | 13,461 | 14,906 |
Interest Expense | -1,070 | -1,167 | -1,560 | -1,607 | -817.62 | -318.2 |
Interest & Investment Income | 151.03 | 112.79 | 87.35 | 116.44 | 158.02 | 105.82 |
Currency Exchange Gain (Loss) | 274.5 | -94.14 | 517.81 | 24.07 | 72.58 | 466.16 |
Other Non Operating Income (Expenses) | -102.99 | 42.09 | 180.77 | 99.77 | 76.15 | 150.26 |
EBT Excluding Unusual Items | 9,438 | 8,259 | 8,160 | 6,696 | 12,950 | 15,310 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -10.57 |
Gain (Loss) on Sale of Assets | 11.35 | 11.34 | 10.58 | -0.73 | -1.83 | -407.4 |
Pretax Income | 9,450 | 8,270 | 8,171 | 6,695 | 12,948 | 14,892 |
Income Tax Expense | 1,623 | 1,279 | 1,458 | 744.27 | 2,327 | 3,166 |
Net Income | 7,827 | 6,991 | 6,713 | 5,951 | 10,622 | 11,726 |
Net Income to Common | 7,827 | 6,991 | 6,713 | 5,951 | 10,622 | 11,726 |
Net Income Growth | 18.68% | 4.14% | 12.80% | -43.97% | -9.42% | 17.88% |
Shares Outstanding (Basic) | - | 3 | 3 | 3 | 4 | 4 |
Shares Outstanding (Diluted) | - | 3 | 3 | 3 | 4 | 4 |
Shares Change (YoY) | - | -1.59% | -0.42% | -2.07% | -0.65% | -0.43% |
EPS (Basic) | - | 2045.64 | 1933.01 | 1706.35 | 2982.55 | 3271.30 |
EPS (Diluted) | - | 2045.64 | 1933.01 | 1706.35 | 2982.55 | 3271.30 |
EPS Growth | - | 5.83% | 13.28% | -42.79% | -8.83% | 18.39% |
Free Cash Flow | 12,738 | 14,048 | 3,202 | 6,699 | -3,992 | 9,989 |
Free Cash Flow Per Share | - | 4110.51 | 921.97 | 1920.66 | -1120.99 | 2786.62 |
Gross Margin | 9.99% | 9.62% | 9.86% | 10.32% | 11.53% | 14.27% |
Operating Margin | 5.15% | 4.82% | 4.79% | 4.84% | 6.96% | 9.30% |
Profit Margin | 3.96% | 3.60% | 3.60% | 3.57% | 5.49% | 7.32% |
Free Cash Flow Margin | 6.44% | 7.23% | 1.72% | 4.02% | -2.06% | 6.23% |
EBITDA | 16,551 | 15,768 | 15,574 | 14,209 | 17,436 | 19,123 |
EBITDA Margin | 8.37% | 8.12% | 8.36% | 8.52% | 9.02% | 11.93% |
D&A For EBITDA | 6,365 | 6,403 | 6,640 | 6,146 | 3,975 | 4,217 |
EBIT | 10,186 | 9,365 | 8,935 | 8,063 | 13,461 | 14,906 |
EBIT Margin | 5.15% | 4.82% | 4.79% | 4.84% | 6.96% | 9.30% |
Effective Tax Rate | 17.17% | 15.46% | 17.84% | 11.12% | 17.97% | 21.26% |
Advertising Expenses | - | 1.89 | 4.76 | 14.86 | 3.05 | 1 |